Format

Send to

Choose Destination
Haematologica. 2016 Jan;101(1):e15-9. doi: 10.3324/haematol.2015.128546. Epub 2015 Dec 3.

STAT1 activation in association with JAK2 exon 12 mutations.

Author information

1
Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, Addenbrooke's Hospital, UK Department of Haematology, University of Cambridge, Cambridge, UK.
2
Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, University of Cambridge, Cambridge, UK.
3
Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain.
4
Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
5
Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
6
Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK.
7
University Hospital of Ulm, Department of Internal Medicine III, Germany.
8
Institut Bergonie, Department of Hematology, Bordeaux, France.
9
Laboratoire d'Hematologie, CHU de Bordeaux and Laboratorie Hematopoiese Leucemique et Cibles Thérapeutiques, INSERM U 1035, Universite Bordeaux Segalen, Bordeaux, France.
10
University of Bordeaux, Etablissement Français du Sang, France.
11
Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, Addenbrooke's Hospital, UK Department of Haematology, University of Cambridge, Cambridge, UK arg1000@cam.ac.uk.

KEYWORDS:

JAK2 exon 12; STAT1; activation; mutations

PMID:
26635038
PMCID:
PMC4697901
DOI:
10.3324/haematol.2015.128546
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center